Foundry Partners, LLC Blueprint Medicines Corp Transaction History

Foundry Partners, LLC

$1.95 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$82.78 - $101.0 $414,065 - $505,202	-5,002 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$90.71 - $108.28 $208,542 - $248,935	-2,299 Reduced 31.49%	5,002 $486,000
Q4 2020 Feb 04, 2021	SELL	$92.08 - $124.48 $3,130 - $4,232	-34 Reduced 0.46%	7,301 $819,000
Q3 2020 Oct 23, 2020	SELL	$66.45 - $92.7 $521,831 - $727,973	-7,853 Reduced 51.71%	7,335 $680,000
Q2 2020 Aug 03, 2020	SELL	$57.09 - $79.27 $32,998 - $45,818	-578 Reduced 3.67%	15,188 $1.19 Million
Q4 2019 Feb 10, 2020	SELL	$66.73 - $82.59 $81,810 - $101,255	-1,226 Reduced 7.22%	15,766 $1.26 Million
Q3 2019 Oct 23, 2019	BUY	$72.9 - $101.41 $59,194 - $82,344	812 Added 5.02%	16,992 $1.25 Million
Q2 2019 Jul 18, 2019	SELL	$73.54 - $97.8 $3,456 - $4,596	-47 Reduced 0.29%	16,180 $1.53 Million
Q1 2019 Apr 22, 2019	BUY	$48.7 - $86.6 $64,478 - $114,658	1,324 Added 8.88%	16,227 $1.3 Million
Q4 2018 Jan 10, 2019	BUY	$45.57 - $74.26 $1,139 - $1,856	25 Added 0.17%	14,903 $1.16 Million
Q4 2018 Jan 10, 2019	SELL	$45.57 - $74.26 $1,139 - $1,856	-25 Reduced 0.17%	14,878 $802,000
Q3 2018 Oct 17, 2018	SELL	$58.91 - $78.32 $1,354 - $1,801	-23 Reduced 0.15%	14,903 $1.16 Million
Q2 2018 Jul 19, 2018	SELL	$60.96 - $101.18 $59,496 - $98,751	-976 Reduced 6.14%	14,926 $948,000
Q1 2018 May 16, 2018	SELL	$73.28 - $102.95 $2,931 - $4,118	-40 Reduced 0.25%	15,902 $1.46 Million
Q4 2017 Jan 25, 2018	SELL	$62.91 - $88.32 $1.3 Million - $1.82 Million	-20,638 Reduced 56.42%	15,942 $1.2 Million
Q3 2017 Oct 31, 2017	BUY	$42.37 - $69.67 $1.55 Million - $2.55 Million	36,580	36,580 $2.55 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Account